CD1D and Parkinson disease: To investigate the potential of targeting NKT cells at regulating the neuroinflammatory process in DLB/PD models, we treated α-syn transgenic (tg) mice (e.g.: Thy1 promoter line 61) with an antibody against CD1d which is a glycoprotein expressed in antigen presenting cells (APCs).